About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Possible Drug Target to Reduce Allergic Reactions

by Julia Samuel on February 26, 2018 at 5:34 PM
Font : A-A+

Possible Drug Target to Reduce Allergic Reactions

Not one but several proteins can interact in blood vessels and cause a severe allergic reaction known as anaphylaxis.

Prospects for inhibiting the most dangerous symptoms of allergic reactions may be brighter with the publication of a new study that identifies a possible target for drug therapies.

Advertisement


Research conducted at Cincinnati Children's Hospital Medical Center and published in the Journal of Allergy and Clinical Immunology found that several proteins can interact in blood vessels to intensify the respiratory and circulatory symptoms of a severe allergic reaction known as anaphylaxis. Pharmaceuticals that target these proteins, including a drug approved to treat a chronic skin condition, may be able to moderate reactions and make anaphylaxis less deadly.

An allergic reaction occurs when the immune system recognizes an otherwise harmless protein (the allergen) as an invading threat, setting off a chain of events that lead to disease symptoms. The new findings center on the vascular epithelium (VE) cells that line the inner surfaces of blood vessels. Neighboring VE cells form a barrier that prevents fluid loss. During severe anaphylaxis, disrupting the VE barrier allows fluid to leak from the blood vessels into surrounding tissues, which can lead to shock, respiratory failure, and death.
Advertisement

"These studies show that we need to think beyond the immune cells with respect to food allergy as it is becoming increasingly clear that non-immune cells can also influence anaphylaxis," explained the principal investigator, Dr. Simon Hogan.

Therapies to prevent the life-threatening symptoms of anaphylaxis could transform the lives of 15 million Americans with food allergies. The studies received support from Food Allergy Research & Education (FARE), the world's largest private source of funding for food allergy research, which granted Hogan a multi-year award in 2015.

"For most individuals with food allergies, a top research priority is the development of therapies to control the severe symptoms that make food allergy reactions so unpredictable and dangerous," said Mary Jane Marchisotto, SVP of Research and International Operations at FARE.

Most allergy symptoms are triggered when a small molecule called histamine is released from white blood cells that normally promote healing and fight infection. Other molecules released by white blood cells during an allergic reaction include a small protein called interleukin 4 (IL-4). Researchers in the Hogan laboratory examined the interaction of these molecules and the IL-4 receptor protein on VE barrier function of blood vessels in anaphylaxis.

Studies revealed that anaphylaxis was linked with loss of VE barrier integrity in response to histamine. The authors showed that the histamine response is more severe in the presence of IL-4 signaling and that higher levels of IL-4 and histamine increased the loss of fluid from blood vessels to surrounding tissue and made anaphylaxis more severe.

The finding that increased fluid loss is dependent on the activity of the IL-4 receptor suggests that drugs targeting IL-4 receptor activity may be useful in limiting anaphylaxis symptoms. One such drug has already been approved for treating moderate to severe eczema.

Hogan envisions a possible role for this research in preventing severe reactions during allergen immunotherapy, in which repeated allergen exposure is used to make the patient's immune system less sensitive to the allergen.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Sensory Processing Disorder (SPD)
First Dose of COVID-19 Vaccines May Improve Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Allergy Drug Toxicity Signature Drug Toxicity Dealing with Pollen Allergy Drugs Banned in India 

Recommended Reading
Anaphylaxis
Anaphylaxis, the acute life-threatening allergic reaction caused by insect bites or eating certain ....
Angioedema
Angioedema is a condition that causes leakage of blood vessels resulting in the swelling of deeper ....
Sulphonamide Allergy
Sulphonamide allergy is one of the commonest drug allergy reactions. It is seen to antibiotics ......
Hives Symptom Evaluation
Hives are a common result of allergic reactions. In addition, physical factors, systemic diseases .....
Allergy
An allergy is a hypersensitive disorder of immune system. Substances that often cause allergic react...
Dealing with Pollen Allergy
The plants around you that give you sniffles in your nose at specific time of the year are the sourc...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use